Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Characterization of murine interleukin B by a monoclonal antibody

Abstract

Interleukin B (IL-B) (ref. 1), formerly termed BEF (B-cell-derived enhancing factor)2,3 or IL-B4 (ref. 4), was originally described as a non-immunoglobulin regulatory factor spontaneously produced by B lymphocytes and B-cell lines that enhances the in vitro antigen-driven antibody response of unfractionated spleen cells stimulated by thymus-dependent antigens2,3. Since then we have examined the function of interleukin B in a number of immune reactions, both in vitro and in vivo5, and found that it inhibits the activation of suppressor T lymphocytes3,6–9. We report here the production of two monoclonal antibodies (mAb) that specifically inhibit interleukin B activity. The use of these mAb in the purification and characterization of IL-B is described. IL-B from both normal and transformed B cells consists of two subunits of similar size and amino-acid composition. The structure of interleukin B and its specific behaviour in biological assay distinguish it from many other known lymphokines.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. del Guercio, P., Marcelletti, J. F. & Katz, D. H. Immun. Today 7, 97–98 (1986).

    Article  CAS  Google Scholar 

  2. del Guercio, P., Poirier, M.-F. & Brugere, S. Cell Immun. 72, 316–325 (1982).

    Article  CAS  Google Scholar 

  3. del Guercio, P., Brugere, S. & Poirier, M.-F. Cell Immun. 73, 360–364 (1982).

    Article  CAS  Google Scholar 

  4. del Guercio, P., Marcelletti, J. F., Zuberi, R. I., del Guercio, M.-F. & Katz, D. H. J. cell Biochem. Suppl. 10A, 84 (1986).

    Google Scholar 

  5. del Guercio, P. & Katz, D. H. CRC Crit. Rev. Immun. 6, 185–212 (1986).

    CAS  Google Scholar 

  6. del Guercio, P. & Poirier, M.-F. J. Immun. 131, 1283–1288 (1983).

    CAS  PubMed  Google Scholar 

  7. del Guercio, P., Fridman, W. H., del Guercio, M.-F. & Katz, D. H. in Advances in Gene Technology: Molecular Biology of the Immune System (eds Streilen, J. W. et al.) 175–176 (Cambridge University Press, 1985).

    Google Scholar 

  8. del Guercio, P., del Guercio, M.-F., Fridman, W. H. & Katz, D. H. J. Immun. 138, 3295–3299 (1987).

    CAS  PubMed  Google Scholar 

  9. del Guercio, P., Zanetti, M., del Guercio, M.-F. & Katz, D. H. J. Immun. 134, 3926–3933 (1985).

    CAS  PubMed  Google Scholar 

  10. Kearney, J. F., Radbruch, A., Liesegang, B. & Rajewsky, K. J. Immun. 123, 1548–1550 (1979).

    CAS  Google Scholar 

  11. Bazin, H. in Protides of the Biological Fluids (ed. Peeters, H.) 615–618 (Pergamon, New York, 1982).

    Google Scholar 

  12. del Guercio, P., del Guercio, M.-F., Zanetti, M. & Katz, D. H. Cell Immun. 98, 337–340 (1986).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

del Guercio, P., del Guercio, MF. & Katz, D. Characterization of murine interleukin B by a monoclonal antibody. Nature 329, 445–447 (1987). https://doi.org/10.1038/329445a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/329445a0

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing